Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.

Nature medicine·2026
Same author

Pre-Crohn's Disease Stool From Discordant Siblings Promotes the Development of Colitis in Germ-Free Mice.

Gastroenterology·2026
Same author

Long-read metagenomics for strain tracking after faecal microbiota transplant.

Nature microbiology·2025
Same author

Searching for the perfect match: MINDFUL trial pairs FMT and fiber for ulcerative colitis.

Med (New York, N.Y.)·2025
Same author

Long read metagenomics-based precise tracking of bacterial strains and genomic changes after fecal microbiota transplantation.

bioRxiv : the preprint server for biology·2025
Same author

Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses.

Science advances·2025
Same journal

Vitamin B6 produced by gut microbiome regulates host behavioral phenotypes through dopaminergic metabolism.

Gut microbes·2026
Same journal

Microbial metabolite Urolithin A protects against inorganic arsenic-induced gut barrier dysfunction in humanized <i>AS3MT</i> mice.

Gut microbes·2026
Same journal

Genome-scale metabolic models predict diet- and lifestyle-driven shifts of ecological interactions in the gut microbiome.

Gut microbes·2026
Same journal

Early risk stratification of late-onset sepsis in very preterm infants by intestinal microbiota profiling: a multicenter case-control validation study.

Gut microbes·2026
Same journal

Multi-omics analysis of saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression.

Gut microbes·2026
Same journal

Is <i>Fusobacterium nucleatum</i> the key mediator between oral infections and systemic diseases? Mechanistic insights and therapeutic implications.

Gut microbes·2026
See all related articles

Related Experiment Video

Updated: May 7, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.2K

Assessing live microbial therapeutic transmission.

Jeremiah J Faith1,2

  • 1Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Gut Microbes
|January 2, 2025
PubMed
Summary
This summary is machine-generated.

Fecal microbiota transplantation (FMT) and live biotherapeutics show promise for treating diseases beyond recurrent Clostridioides difficile infection. Standardized methods are needed to characterize these therapies and monitor microbial engraftment for successful clinical application.

Keywords:
Microbiomefecal microbiota transplantationlive biotherapeutic productmicrobial therapeuticsstrain tracking

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.0K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K

Related Experiment Videos

Last Updated: May 7, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.2K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.0K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pharmacology

Background:

  • Fecal microbiota transplantation (FMT) and defined live biotherapeutic products (LBPs) have emerged as successful treatments for recurrent Clostridioides difficile infection.
  • Their application in other diseases is promising but requires consistent quantitative frameworks for drug characterization and efficacy assessment.
  • Mixed clinical results highlight the need for better understanding of dose, composition, and strain engraftment dynamics.

Purpose of the Study:

  • To establish quantitative frameworks for characterizing FMT and LBPs.
  • To assess the impact of drug dose and composition on microbial strain engraftment.
  • To guide the identification of minimally sufficient microbial consortia for therapeutic use.

Main Methods:

  • Review and description of strain detection approaches for microbial therapeutics.
  • Analysis of data requirements for various strain detection methods.
  • Evaluation of clinical trial designs suitable for assessing FMT and LBP efficacy.

Main Results:

  • Strain detection methods are crucial for advancing the therapeutic use of microbial products.
  • Different methods are suited for specific applications, requiring distinct data inputs.
  • Appropriate clinical trial designs are essential for monitoring drug properties and engraftment outcomes.

Conclusions:

  • Standardized quantitative frameworks and strain detection methods are vital for optimizing FMT and LBP therapies.
  • Understanding microbial function and host interactions is key to developing effective treatments.
  • This work provides guidance on selecting appropriate methods and trial designs for future research and clinical application.